Common Sensing and Right Ventricular Automatic Capture (COGNATE)

Common Sensing and Right Ventricular Automatic Capture

This study will collect data on features for future pacemakers via an external non-implantable system.

COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.

Inclusion Criteria:

• Patients who are scheduled to receive either Pacemaker (dual chamber) or CRT-P devices based on physician discretion
• Patients who are willing and capable of participating in all testing associated with this Clinical Investigation
• Patients who are age 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria:

• Patient enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study
• Patients with a prosthetic mechanical tricuspid heart valve
• Women who are pregnant